Sort
51,593 grants matching “hepatitis”
Glucagon secretion and action in humans
$499,634Adrian Vella · Mayo Clinic Rochester · R01 · FY2024 · DK
Understanding the role of an aberrant hepatic nuclear transcription circuit in prostate cancer tumorigenesis and castration resistance
$499,575Yu Chen · Sloan-Kettering Inst Can Research · R01 · FY2020 · CA
Understanding the role of an aberrant hepatic nuclear transcription circuit in prostate cancer tumorigenesis and castration resistance
$499,575Yu Chen · Sloan-Kettering Inst Can Research · R01 · FY2021 · CA
CD24 Polymorphism and Acetaminophen Toxicity
$499,564Pan Zheng · University Of Michigan At Ann Arbor · RC1 · FY2009 · GM
HIV HCV Coinfection Antiviral Therapy and Fibrosis
$499,538David L Thomas · Johns Hopkins University · R01 · FY2008 · DA
Hepatic Steatosis Quantification with Ultrasound
$499,499Shigao Chen · Mayo Clinic Rochester · R01 · FY2025 · DK
HEPATITIS C CLINICAL TRIAL-CLINICAL CENTERS
$499,499Univ Of Massachusetts Med Sch Worcester · N01 · FY2000 · DK
Identification of metabolic regulators of glycerolipid synthesis and storage
$499,389Kivanc Birsoy · Rockefeller University · R01 · FY2021 · DK
Immune regulation and co-stimulation in treatment outcome of chronic hepatitis B
$499,337Kyong-Mi Chang · University Of Pennsylvania · U01 · FY2011 · DK
Mechanisms of Antiviral Action of Human Interferon
$499,330Kathryn Zoon · National Institute Of Allergy And Infectious Diseases · ZIA · FY2012 · AI
Mechanisms of NAT2 Regulation of Insulin Resistance and Mitochondrial Dysfunction
$499,314Joshua Wiley Knowles · Stanford University · R01 · FY2022 · DK
The Role of the Intestinal Mycobiome in Alcoholic Liver Disease
$499,298Bernd G. Schnabl · University Of California, San Diego · R01 · FY2023 · AA
Mechanisms of luminal protein targeting in kidney and hepatic epithelial cells
$499,272Anne Muesch · Albert Einstein College Of Medicine · R01 · FY2014 · DK
Mechanisms of luminal protein targeting in kidney and hepatic epithelial cells
$499,272Anne Muesch · Albert Einstein College Of Medicine, Inc · R01 · FY2015 · DK
Mechanisms of luminal protein targeting in kidney and hepatic epithelial cells
$499,272Anne Muesch · Albert Einstein College Of Medicine · R01 · FY2012 · DK
Project ECHO Hepatitis C Ambulatory Care Quality Improvement in New Mexico throug
$499,196Sanjeev Arora · University Of New Mexico · R18 · FY2009 · HS
Tulane/LSU HIV/AIDS Clinical Trials Networks Unit
$499,167Russell Barrett Van Dyke · Tulane University Of Louisiana · U01 · FY2007 · AI
A Glucocorticoid Receptor-SETDB2 Co-Regulated Liver Metabolic Gene Program
$499,165Timothy F Osborne · Johns Hopkins University · R01 · FY2024 · DK
Leveraging Evidence-based practices for Ambulatory VTE Patients to be Safe with Direct Oral Anticoagulants: LEAVE Safe with DOACs
$499,160Alok Kapoor · Univ Of Massachusetts Med Sch Worcester · R18 · FY2020 · HS
The Role of the Intestinal Mycobiome in Alcoholic Liver Disease
$499,159Bernd G. Schnabl · University Of California, San Diego · R01 · FY2025 · AA
The Role of the Intestinal Mycobiome in Alcoholic Liver Disease
$499,159Bernd G. Schnabl · University Of California, San Diego · R01 · FY2024 · AA
HEPADNAVIRUS INFECTIONS AND LIVER CANCER
$499,013Institute For Cancer Research · R01 · FY2003 · AI
Impact of Tetracycline Antibiotics on Skeletal Maturation
$498,995Caroline Westwater · Medical University Of South Carolina · R01 · FY2024 · AR
Project 3 Immunotherapeutic Targeting of SLC45A2 for Treatment of Uveal Melanoma
$498,957Cassian Yee · University Of Tx Md Anderson Can Ctr · P50 · FY2020 · CA
Sterile inflammation and pyroptotic cell death in liver fibrosis
$498,925Ariel Feldstein · University Of California, San Diego · R01 · FY2017 · DK